Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

A Community-Driven Intervention for Improving Biospecimen Donation in African American Communities.

Patel K, Inman W, Gishe J, Johnson O, Brown E, Kanu M, Theriot R, Sanderson M, Hull P, Hargreaves M.

J Racial Ethn Health Disparities. 2018 Feb;5(1):15-23. doi: 10.1007/s40615-017-0336-2. Epub 2017 Feb 8.

PMID:
28181200
2.

Zoonotic Leprosy in the Southeastern United States.

Sharma R, Singh P, Loughry WJ, Lockhart JM, Inman WB, Duthie MS, Pena MT, Marcos LA, Scollard DM, Cole ST, Truman RW.

Emerg Infect Dis. 2015 Dec;21(12):2127-34. doi: 10.3201/eid2112.150501.

3.

All-human microphysical model of metastasis therapy.

Wheeler SE, Borenstein JT, Clark AM, Ebrahimkhani MR, Fox IJ, Griffith L, Inman W, Lauffenburger D, Nguyen T, Pillai VC, Prantil-Baun R, Stolz DB, Taylor D, Ulrich T, Venkataramanan R, Wells A, Young C.

Stem Cell Res Ther. 2013;4 Suppl 1:S11. doi: 10.1186/scrt372. Epub 2013 Dec 20. Review.

4.

Challenges in using cultured primary rodent hepatocytes or cell lines to study hepatic HDL receptor SR-BI regulation by its cytoplasmic adaptor PDZK1.

Tsukamoto K, Buck L, Inman W, Griffith L, Kocher O, Krieger M.

PLoS One. 2013 Jul 23;8(7):e69725. doi: 10.1371/journal.pone.0069725. Print 2013.

5.

Lipophilic stinging nettle extracts possess potent anti-inflammatory activity, are not cytotoxic and may be superior to traditional tinctures for treating inflammatory disorders.

Johnson TA, Sohn J, Inman WD, Bjeldanes LF, Rayburn K.

Phytomedicine. 2013 Jan 15;20(2):143-7. doi: 10.1016/j.phymed.2012.09.016. Epub 2012 Oct 23.

6.

Natural product libraries to accelerate the high-throughput discovery of therapeutic leads.

Johnson TA, Sohn J, Inman WD, Estee SA, Loveridge ST, Vervoort HC, Tenney K, Liu J, Ang KK, Ratnam J, Bray WM, Gassner NC, Shen YY, Lokey RS, McKerrow JH, Boundy-Mills K, Nukanto A, Kanti A, Julistiono H, Kardono LB, Bjeldanes LF, Crews P.

J Nat Prod. 2011 Dec 27;74(12):2545-55. doi: 10.1021/np200673b. Epub 2011 Nov 30.

7.
8.

Additional insights on the bastadins: isolation of analogues from the sponge Ianthella cf. reticulata and exploration of the oxime configurations.

Calcul L, Inman WD, Morris AA, Tenney K, Ratnam J, McKerrow JH, Valeriote FA, Crews P.

J Nat Prod. 2010 Mar 26;73(3):365-72. doi: 10.1021/np9005986.

9.

Perfused multiwell plate for 3D liver tissue engineering.

Domansky K, Inman W, Serdy J, Dash A, Lim MH, Griffith LG.

Lab Chip. 2010 Jan 7;10(1):51-8. doi: 10.1039/b913221j. Epub 2009 Oct 22.

10.

A beta-carboline alkaloid from the Papua New Guinea marine sponge hyrtios reticulatus.

Inman WD, Bray WM, Gassner NC, Lokey RS, Tenney K, Shen YY, Tendyke K, Suh T, Crews P.

J Nat Prod. 2010 Feb 26;73(2):255-7. doi: 10.1021/np9005426.

11.

Liver tissue engineering in the evaluation of drug safety.

Dash A, Inman W, Hoffmaster K, Sevidal S, Kelly J, Obach RS, Griffith LG, Tannenbaum SR.

Expert Opin Drug Metab Toxicol. 2009 Oct;5(10):1159-74. doi: 10.1517/17425250903160664. Review.

12.

Perfused microreactors for liver tissue engineering.

Domansky K, Inman W, Serdy J, Griffith L.

Conf Proc IEEE Eng Med Biol Soc. 2005;7:7490-2.

PMID:
17282013
13.

Novel antihyperglycemic terpenoid-quinones from Pycnanthus angolensis.

Fort DM, Ubillas RP, Mendez CD, Jolad SD, Inman WD, Carney JR, Chen JL, Ianiro TT, Hasbun C, Bruening RC, Luo J, Reed MJ, Iwu M, Carlson TJ, King SR, Bierer DE, Cooper R.

J Org Chem. 2000 Oct 6;65(20):6534-9.

PMID:
11052098
14.

"Pathogens invade 21st century"!

Inman WB.

Nursing. 2000 Aug;30(8):22-4. No abstract available.

PMID:
10983114
15.

Antihyperglycemic sesquiterpenes from Psacalium decompositum.

Inman WD, Luo J, Jolad SD, King SR, Cooper R.

J Nat Prod. 1999 Aug;62(8):1088-92.

PMID:
10479309
16.

Tuberculosis in Tennessee: preparing for the 21st century.

Mehta JB, Inman W, Roy TM.

Tenn Med. 1997 Apr;90(4):135-7. No abstract available.

PMID:
9088150
17.

Testing for adverse reactions using prescription event monitoring.

Andrew JE, Prescott P, Smith TM, Inman WH, Kubota K.

Stat Med. 1996 May 30;15(10):987-1002.

PMID:
8783437
18.

Attitudes to adverse drug reaction reporting.

Inman WH.

Br J Clin Pharmacol. 1996 May;41(5):434-5. No abstract available.

19.
20.

Jasplakinolide's inhibition of the growth of prostate carcinoma cells in vitro with disruption of the actin cytoskeleton.

Senderowicz AM, Kaur G, Sainz E, Laing C, Inman WD, Rodríguez J, Crews P, Malspeis L, Grever MR, Sausville EA, et al.

J Natl Cancer Inst. 1995 Jan 4;87(1):46-51.

PMID:
7666463
21.
22.

Postmarketing surveillance. Avoid promotional studies.

Inman WH.

BMJ. 1994 Sep 3;309(6954):608-9. No abstract available.

23.

Prescription-event monitoring of 10,401 patients treated with fluvoxamine.

Edwards JG, Inman WH, Wilton L, Pearce GL.

Br J Psychiatry. 1994 Mar;164(3):387-95.

PMID:
7993416
24.

Angiotensin converting enzyme inhibitors and asthma.

Inman WH, Wilton L, Pearce G, Mann RD.

BMJ. 1994 Feb 26;308(6928):593-4. No abstract available.

26.

Terminology in prescription-event monitoring.

Kubota K, Inman WH.

Eur J Clin Pharmacol. 1994;46(6):497-500.

PMID:
7995314
27.

Prescriber profile and postmarketing surveillance.

Inman WH, Pearce G.

Lancet. 1993 Dec 11;342(8885):1491. No abstract available.

PMID:
7902513
28.

Return of normal gait patterns after anterior cruciate ligament reconstruction.

Timoney JM, Inman WS, Quesada PM, Sharkey PF, Barrack RL, Skinner HB, Alexander AH.

Am J Sports Med. 1993 Nov-Dec;21(6):887-9.

PMID:
8291645
29.

Prescriber profile and post-marketing surveillance.

Inman W, Pearce G.

Lancet. 1993 Sep 11;342(8872):658-61.

PMID:
8103150
30.

Studies on the muscle-paralyzing components of the juice of the banana plant.

Singh YN, Inman WD, Johnson A, Linnell EJ.

Arch Int Pharmacodyn Ther. 1993 Jul-Aug;324:105-13.

PMID:
8297182
31.

Bronchodilator treatment in asthma. Manufacturers underestimate mortality from asthma.

Inman WH.

BMJ. 1993 Jun 12;306(6892):1610; author reply 1611. No abstract available.

32.

Tachycardia during cisapride treatment.

Inman W, Kubota K.

BMJ. 1992 Oct 24;305(6860):1019. No abstract available.

33.

Cardiorespiratory distress after sumatriptan given by injection.

Inman W, Kubota K.

BMJ. 1992 Sep 19;305(6855):714. No abstract available.

34.

Cannock Community Hospital. Measuring up.

Inman WC.

Health Estate J. 1991 Nov;45(9):suppl 10-4.

PMID:
10115735
35.

Prescription-event monitoring of 10,895 patients treated with alprazolam.

Edwards JG, Inman WH, Pearce GL, Rawson NS.

Br J Psychiatry. 1991 Mar;158:387-92.

PMID:
2036539
36.

The outcome of nonoperatively treated complete tears of the anterior cruciate ligament in active young adults.

Barrack RL, Bruckner JD, Kneisl J, Inman WS, Alexander AH.

Clin Orthop Relat Res. 1990 Oct;(259):192-9.

PMID:
2208856
37.

Prescription-event monitoring: methodology and recent progress.

Rawson NS, Pearce GL, Inman WH.

J Clin Epidemiol. 1990;43(5):509-22.

PMID:
2324790
38.

Diltiazem and heart block.

Waller PC, Inman WH.

Lancet. 1989 Mar 18;1(8638):617. No abstract available.

PMID:
2564139
39.
40.

Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring.

Inman WH, Rawson NS, Wilton LV, Pearce GL, Speirs CJ.

BMJ. 1988 Oct 1;297(6652):826-9.

41.

Safety of mianserin.

Inman WH.

Lancet. 1988 Sep 17;2(8612):683-4. No abstract available.

PMID:
2901538
42.

The role of epidermal growth factor in skin diseases.

King LE Jr, Ellis DL, Gates RE, Inman WH, Stoscheck CM, Fava RA, Nanney LB.

Am J Med Sci. 1988 Sep;296(3):154-8. Review. No abstract available.

PMID:
3052058
43.

Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition.

Slater EE, Merrill DD, Guess HA, Roylance PJ, Cooper WD, Inman WH, Ewan PW.

JAMA. 1988 Aug 19;260(7):967-70.

PMID:
2840522
45.
46.

Beyond pharmacoepidemiology.

Inman WH.

J Clin Epidemiol. 1988;41(10):997-8. No abstract available.

PMID:
3193144
47.

Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trélat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes.

Ellis DL, Kafka SP, Chow JC, Nanney LB, Inman WH, McCadden ME, King LE Jr.

N Engl J Med. 1987 Dec 17;317(25):1582-7. No abstract available.

PMID:
2825016
48.

Deafness with enalapril and prescription event monitoring.

Inman WH, Rawson NS.

Lancet. 1987 Apr 11;1(8537):872. No abstract available.

PMID:
2882284
49.

Adverse reaction monitoring using cohort identification.

Inman WH, Rawson NS.

Br Med J (Clin Res Ed). 1987 Apr 4;294(6576):902. No abstract available.

50.

Growth factor stimulation of sugar uptake.

Inman WH, Colowick SP.

Methods Enzymol. 1987;146:399-402. No abstract available.

PMID:
3119962

Supplemental Content

Support Center